Nanoprobes with dual modal imaging of magnetic resonance imaging (MRI) and two-photon fluorescence (TPF) can serve as promising platforms for clinical diagnosis. A wide range of molecules and nanoparticles have been investigated as agents for contrast enhanced MRI and fluorescence imaging in cancer diagnosis. However, a single material with dual modal imaging of MRI and TPF is rarely reported. We found that Mn3[Co(CN)6]2 nanocubes can serve as agents for both T1- and T2-weighted MRI, and TPF imaging. The nanocubes coated with silica to form Mn3[Co(CN)6]2@SiO2 core-shell nanocubes were readily internalized by cells without showing cytotoxicity. In vitro tests, the core-shell nanocubes display relatively high longitudinal (r1) and transverse (r2) relaxivities, they also manifest a remarkable T1 and T2 contrast effects at in-vivo imaging of internal organs in Mice. Moreover, the core-shell nanocubes could offer high-resolution cell fluorescence imaging by two-photon excitation (720 nm) or by conventional fluorescence with 403- or 488-nm excitation.
CITATION STYLE
Huang, Y., Hu, L., Zhang, T., Zhong, H., Zhou, J., Liu, Z., … Chen, Q. (2013). Mn3[Co(CN)6]2@SiO2 Core-shell Nanocubes: Novel bimodal contrast agents for MRI and optical imaging. Scientific Reports, 3. https://doi.org/10.1038/srep02647
Mendeley helps you to discover research relevant for your work.